{
  "run_id": "b4dfba9b-48c4-4158-925a-c8181fd5e0e8",
  "prompt_variant_id": "29cf3c2e-2c65-49ce-beca-4a16e0a42849",
  "api_config_name": "model_gpt_4o",
  "test_case_id": "breast_cancer_her2_positive",
  "start_time": "2025-09-01T23:31:48.478228",
  "end_time": "2025-09-01T23:31:50.278052",
  "duration_ms": 1795.9849834442139,
  "success": true,
  "error_message": "",
  "entities_extracted": 15,
  "entities_mapped": 8,
  "extraction_completeness": 0.9375,
  "mapping_accuracy": 0.6666666666666665,
  "precision": 0.8125,
  "recall": 0.8125,
  "f1_score": 0.8125,
  "compliance_score": 1.0,
  "token_usage": 3273,
  "extracted_entities": [
    {
      "text": "HER2-Positive Breast Cancer",
      "type": "condition",
      "attributes": {
        "status": "positive",
        "value": null,
        "unit": null
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "conditionsModule",
        "section_type": "conditions",
        "document_id": "unknown"
      }
    },
    {
      "text": "Metastatic Breast Cancer",
      "type": "condition",
      "attributes": {
        "status": "positive",
        "value": null,
        "unit": null
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "conditionsModule",
        "section_type": "conditions",
        "document_id": "unknown"
      }
    },
    {
      "text": "HER2-positive metastatic breast cancer",
      "type": "condition",
      "attributes": {
        "status": "positive",
        "value": null,
        "unit": null
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "Measurable disease per RECIST 1.1",
      "type": "condition",
      "attributes": {
        "status": "positive",
        "value": null,
        "unit": null
      },
      "confidence": 0.9,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "ECOG performance status 0-1",
      "type": "demographic",
      "attributes": {
        "status": "positive",
        "value": "0-1",
        "unit": null
      },
      "confidence": 0.92,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "Adequate organ function",
      "type": "condition",
      "attributes": {
        "status": "positive",
        "value": null,
        "unit": null
      },
      "confidence": 0.88,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "Prior treatment with Trastuzumab Deruxtecan",
      "type": "exclusion",
      "attributes": {
        "status": "negative",
        "value": null,
        "unit": null
      },
      "confidence": 0.93,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "Active brain metastases",
      "type": "exclusion",
      "attributes": {
        "status": "negative",
        "value": null,
        "unit": null
      },
      "confidence": 0.94,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "Pregnancy or breastfeeding",
      "type": "exclusion",
      "attributes": {
        "status": "negative",
        "value": null,
        "unit": null
      },
      "confidence": 0.91,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "HER2-positive metastatic breast cancer",
      "type": "condition",
      "attributes": {
        "status": "positive",
        "value": null,
        "unit": null
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "descriptionModule",
        "section_type": "description",
        "document_id": "unknown"
      }
    },
    {
      "text": "HER2-positive",
      "type": "biomarker",
      "attributes": {
        "status": "positive",
        "value": null,
        "unit": null
      },
      "confidence": 0.9,
      "source_context": {
        "section_name": "descriptionModule",
        "section_type": "description",
        "document_id": "unknown"
      }
    },
    {
      "text": "trastuzumab-based therapy",
      "type": "exclusion",
      "attributes": {
        "status": "positive",
        "value": null,
        "unit": null
      },
      "confidence": 0.85,
      "source_context": {
        "section_name": "descriptionModule",
        "section_type": "description",
        "document_id": "unknown"
      }
    },
    {
      "text": "HER2-Positive Breast Cancer",
      "type": "condition",
      "attributes": {
        "status": "positive",
        "value": null,
        "unit": null
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "identificationModule",
        "section_type": "identification",
        "document_id": "unknown"
      }
    },
    {
      "text": "HER2-Positive Metastatic Breast Cancer",
      "type": "condition",
      "attributes": {
        "status": "positive",
        "value": null,
        "unit": null
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "identificationModule",
        "section_type": "identification",
        "document_id": "unknown"
      }
    },
    {
      "text": "HER2-Positive",
      "type": "biomarker",
      "attributes": {
        "status": "positive",
        "value": null,
        "unit": null
      },
      "confidence": 0.9,
      "source_context": {
        "section_name": "identificationModule",
        "section_type": "identification",
        "document_id": "unknown"
      }
    }
  ],
  "Mcode_mappings": [
    {
      "resourceType": "Condition",
      "Mcode_element": "CancerCondition",
      "code": {
        "system": "http://hl7.org/fhir/us/Mcode",
        "code": "cancercondition",
        "display": "CancerCondition"
      },
      "value": "HER2-Positive Breast Cancer",
      "mapping_confidence": 0.95,
      "source_text_fragment": "Entity index 0",
      "mapping_rationale": "The entity 'HER2-Positive Breast Cancer' directly maps to the Mcode element 'CancerCondition' as it specifies a type of cancer diagnosis.",
      "id": "626780d0-e15c-45ad-9f16-42301a60bea9",
      "llm_source_text_fragment": "Entity index 0",
      "source_references": []
    },
    {
      "resourceType": "Condition",
      "Mcode_element": "CancerCondition",
      "code": {
        "system": "http://hl7.org/fhir/us/Mcode",
        "code": "cancercondition",
        "display": "CancerCondition"
      },
      "value": "Metastatic Breast Cancer",
      "mapping_confidence": 0.95,
      "source_text_fragment": "Entity index 1",
      "mapping_rationale": "The entity 'Metastatic Breast Cancer' is a specific cancer diagnosis and maps to 'CancerCondition'.",
      "id": "63a9b0c7-592d-46ac-ac78-e503031bfd56",
      "llm_source_text_fragment": "Entity index 1",
      "source_references": []
    },
    {
      "resourceType": "Condition",
      "Mcode_element": "CancerCondition",
      "code": {
        "system": "http://hl7.org/fhir/us/Mcode",
        "code": "cancercondition",
        "display": "CancerCondition"
      },
      "value": "HER2-positive metastatic breast cancer",
      "mapping_confidence": 0.95,
      "source_text_fragment": "Entity index 2",
      "mapping_rationale": "This entity combines HER2 status and metastatic breast cancer, mapping to 'CancerCondition'.",
      "id": "bc482d1f-3031-4c89-85fa-9cf40e00e223",
      "llm_source_text_fragment": "Entity index 2",
      "source_references": []
    },
    {
      "resourceType": "Observation",
      "Mcode_element": "ECOGPerformanceStatus",
      "code": {
        "system": "http://hl7.org/fhir/us/Mcode",
        "code": "ecogperformancestatus",
        "display": "ECOGPerformanceStatus"
      },
      "value": "0-1",
      "mapping_confidence": 0.92,
      "source_text_fragment": "Entity index 4",
      "mapping_rationale": "The ECOG performance status is a standard measure of patient performance and maps to 'ECOGPerformanceStatus'.",
      "id": "d0205016-7763-40ad-a37a-23eef5d53ab2",
      "llm_source_text_fragment": "Entity index 4",
      "source_references": []
    },
    {
      "resourceType": "MedicationStatement",
      "Mcode_element": "CancerRelatedMedication",
      "code": {
        "system": "http://hl7.org/fhir/us/Mcode",
        "code": "cancerrelatedmedication",
        "display": "CancerRelatedMedication"
      },
      "value": "Trastuzumab Deruxtecan",
      "mapping_confidence": 0.93,
      "source_text_fragment": "Entity index 6",
      "mapping_rationale": "Trastuzumab Deruxtecan is a medication used in cancer treatment, mapping to 'CancerRelatedMedication'.",
      "id": "49594ead-1fd4-4cfc-8355-ce493fdd6254",
      "llm_source_text_fragment": "Entity index 6",
      "source_references": []
    },
    {
      "resourceType": "Observation",
      "Mcode_element": "GenomicVariant",
      "code": {
        "system": "http://hl7.org/fhir/us/Mcode",
        "code": "genomicvariant",
        "display": "GenomicVariant"
      },
      "value": "HER2-positive",
      "mapping_confidence": 0.9,
      "source_text_fragment": "Entity index 10",
      "mapping_rationale": "HER2-positive is a biomarker status, mapping to 'GenomicVariant'.",
      "id": "36efe75d-7a47-4ecb-8673-6cb7f99f051a",
      "llm_source_text_fragment": "Entity index 10",
      "source_references": []
    },
    {
      "resourceType": "MedicationStatement",
      "Mcode_element": "CancerRelatedMedication",
      "code": {
        "system": "http://hl7.org/fhir/us/Mcode",
        "code": "cancerrelatedmedication",
        "display": "CancerRelatedMedication"
      },
      "value": "trastuzumab",
      "mapping_confidence": 0.85,
      "source_text_fragment": "Entity index 12",
      "mapping_rationale": "Trastuzumab is a standard HER2-targeted therapy, mapping to 'CancerRelatedMedication'.",
      "id": "277c755a-bb2b-4644-968e-f5bc133bb06f",
      "llm_source_text_fragment": "Entity index 12",
      "source_references": []
    },
    {
      "resourceType": "Observation",
      "Mcode_element": "GenomicVariant",
      "code": {
        "system": "http://hl7.org/fhir/us/Mcode",
        "code": "genomicvariant",
        "display": "GenomicVariant"
      },
      "value": "HER2-Positive",
      "mapping_confidence": 0.9,
      "source_text_fragment": "Entity index 14",
      "mapping_rationale": "HER2-Positive is a biomarker status, mapping to 'GenomicVariant'.",
      "id": "424eb1d3-4e19-4265-80d6-ace45a7162ed",
      "llm_source_text_fragment": "Entity index 14",
      "source_references": []
    }
  ],
  "validation_results": {
    "valid": true,
    "errors": [],
    "warnings": [],
    "compliance_score": 1.0
  }
}